Investigation of the potential effects of metformin on atherothrombotic risk factors in hyperlipidemic rats
- 1 June 2011
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 659 (2-3) , 213-223
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Plasma Fluorescent Oxidation Products as Potential Markers of Oxidative Stress for Epidemiologic StudiesAmerican Journal of Epidemiology, 2007
- Coronary heart disease outcomes in patients receiving antidiabetic agentsPharmacoepidemiology and Drug Safety, 2007
- Short‐term effects of metformin in type 2 diabetesDiabetes, Obesity and Metabolism, 2006
- Metformin Inhibits Proinflammatory Responses and Nuclear Factor-κB in Human Vascular Wall CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Metformin treatment restores the altered microvascular reactivity in neonatal streptozotocin-induced diabetic rats increasing NOS activity, but not NOS expressionLife Sciences, 2005
- Hypolipidemic and antioxidant activities of Asparagus racemosus in hypercholesteremic ratsIndian Journal of Pharmacology, 2005
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Prevention of myocardial lesions in JCR:LA-corpulent rats by nifedipine.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liverBiochimica et Biophysica Acta (BBA) - General Subjects, 1979